Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
FDA has banned U.S. imports of active pharmaceutical ingredients from Ranbaxy Laboratories’ plant in Toansa, India. The agency found that Toansa plant operators retested failed batches of raw materials, intermediates, and finished ingredients in the hope of obtaining acceptable results. Since January 2012, Ranbaxy has been operating under the terms of a consent decree that required the company to pay a fine of $500 million and follow current Good Manufacturing Practices (cGMP) at facilities that were in violation in both Paonta Sahib and Dewas, India.
This article has been sent to the following recipient: